CMAC 2013; 15(2) | CMAC

CMAC 2013; 15(2)

Over the last years, short treatment courses for different infections, including respiratory tract infections, are increasingly more …
Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):86-94
PDF

Hospital-acquired pneumonia (HAP) is a permanent problem of hospitals, especially intensive care units, where multiple factors such as …
Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):95-105
PDF

Objective. To determine bacterial pathogens causing ocular infections and their antimicrobial susceptibility patterns. Materials and …
Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):106-114
PDF

Objective. To determine the most effective antibiotics for therapy of infectious complications of prosthetic joint implantation caused …
Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):115-123
PDF

Ceftaroline fosamil is a novel cephalosporin antibiotic that has a high activity against multiple bacterial pathogens, including …
Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):124-130
PDF

Objective. To assess clinical efficacy and safety of topical combination of bacitracin and neomycin in comparison to topical …
Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):131-142
PDF

Incidence rates of Acinetobacter spp. isolated from tissue specimens and wound samples in patients with severe burns, chronic …
Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):143-146
PDF

Objective. Objectives. To reveal serotypes of Streptococcus pneumoniaе isolated from patients with pneumococcal infections and from …
Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):147-158
PDF

This paper considers safety issues associated with medical therapy of sexually transmitted diseases (STDs). Data supporting safety of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):159-162
PDF